Management of End Stage Renal Disease-Bangladesh Perspective

Harun Ur Rashid*
Kidney Foundation Hospital and Research Institute, Dhaka, Bangladesh

Article Metrics

CrossRef Citations:
Total Statistics:

Full-Text HTML Views: 8122
Abstract HTML Views: 2132
PDF Downloads: 1494
ePub Downloads: 640
Total Views/Downloads: 12388
Unique Statistics:

Full-Text HTML Views: 3417
Abstract HTML Views: 1163
PDF Downloads: 997
ePub Downloads: 418
Total Views/Downloads: 5995

Creative Commons License
© Harun Ur Rashid; Licensee Bentham Open.

open-access license: This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.

* Address correspondence to this author at the Plot No. 5/2, Road No. 1, Section-2, Mirpur, Dhaka-1216, Bangladesh; Tel: 8055827, 8053786; E-mail:


End stage renal disease (ESRD) is an important cause of morbidity and mortality throughout the world. The treatment of renal replacement therapy (RRT) for patients with ESRD is expensive. There is a direct relationship between per capita income and treatment of ESRD. Eighty five per cent of the world’s population lives in low income or middle-income countries, where the mortality is highest in patients with chronic kidney disease.

The future perspective is not satisfactory for Bangladesh where treatment of ESRD is out of reach for majority of people. Effort should made for prevention and treatment of CKD at an initial stage of disease.

Keywords: Chronic kidney disease, cost of treatment, end stage renal disease, renal replacement therapy..